Serum or plasma is frequently utilized in biomedical research; however, its application is
impeded by the requirement for invasive sample collection. The non-invasive nature of urine …

Urinary proteomics has become one of the most attractive topics in disease biomarker
discovery. MS‐based proteomic analysis has advanced continuously and emerged as a …

The promises of data-independent acquisition (DIA) strategies are a comprehensive and
reproducible digital qualitative and quantitative record of the proteins present in a sample …

Prediction of prostate cancer in primary care is typically based upon serum total prostate-
specific antigen (tPSA) and digital rectal examination results. However, these tests lack …

Introduction: Although prostate cancer constitutes one of the most important, death-related
diseases in the male population, there is still a need for identification of sensitive biomarkers …

Prostate cancer (CaP) is the most common cancer in men and the second leading cause of
cancer deaths in males in Australia. Although serum prostate-specific antigen (PSA) has …

There is a growing need for high throughput diagnostic tools for early diagnosis and
treatment monitoring of prostate cancer (PCa) in Africa. The role of cancer-testis antigens …

Proteomic tools can only be implemented in clinical settings if high-throughput, automated,
sensitive, and accurate methods are developed. This has driven researchers to the edge of …

Liquid biopsy technologies have the potential to transform cancer patient management as it
offers non-invasive diagnosis and real-time monitoring of disease progression and treatment …

Prostate cancer (PCa) is the most common cause of cancer death among African men. The
presence of tumor-specific variations in cell-free DNA (cfDNA), such as mutations …